HQL News and Press, TeklaLife Sciences Investors From 05/04/22

THW is a rare healthcare fund that performed well in April 2022 as well as in past 3 months and 3 years. THW is relatively better protected from market risk due to exposure in global equity markets. THW’s stock selection is impressive, and top investments generated high pos...

With index investing, there's no escape from a roller coaster ride. For most people, especially retirees, it's very difficult to tolerate large and deep drawdowns. Retirees and conservative investors need income, growth to meet inflation, and most importantly, conservation of capital ...

HQL pays regular quarterly dividends with a close to double digit yield, and despite poor price growth over medium and long run, HQL’s total return is impressive. In the past three months, a dividend cut and extension of buyback period played a significant role in price movemen...

Tekla Capital's managed funds have announced one-year extension of their stock buyback program to now expire on June. 14, 2023. It comes from Tekla Healthcare Opportunities Fund (THQ +0.6%), Tekla Healthcare Investors (HQH +1.3%), Tekla World Healthcare Fund (THW +0.7%), and Tekla Life Scienc...

Tekla Life Sciences (NYSE:HQL) declares $0.39/share quarterly dividend, -7.1% decrease from prior dividend of $0.42. Forward yield 8.86% Payable March 31; for shareholders of record Feb. 25; ex-div Feb. 24. See HQL Dividend Scorecard, Yield Chart, & Dividend Growth. For further details ...

The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech. After the sell-off, biotech companies' valuation is close to the 2018 level even tho...

HQL pays quarterly dividends. Even during the pandemic, its performance has been better than its peers. Current prices look attractive. For further details see: Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

As dividend investors—and closed-end fund (CEF) investors, specifically—we know to stay the course when market corrections hit: we don’t want to sell and cut off our precious payouts! That’s the opposite of the fanboys and girls who dabble in crypto, prof...

These days, everyone’s in a tizzy about rising interest rates. But what if I told you that this panic is overblown—and it’s setting us up for some very nice windows to buy some top-quality high-yield funds throwing off payouts of 7% and up? Why do I think it...

I put some capital to work through the month of November in 5 different funds. Black Friday wasn't just a day for shoppers in physical stores, but with the stock market decline, investors got a chance to snag some values too. The Omicron variant of COVID puts uncertainty in the ma...